Chronic Liver Disease: Latest Research in Pathogenesis, Detection and Treatment

Affiliations

¹ Department of Molecular Medicine, University of Pavia, 27100 Pavia, Italy.
² Department of Clinical and Biological Sciences, University of Turin, 10125 Turin, Italy.

Editorial

Silvia De Siervi et al. Int J Mol Sci. 2023.

. 2023 Jun 25;24(13):10633.

doi: 10.3390/ijms241310633.

¹ Department of Molecular Medicine, University of Pavia, 27100 Pavia, Italy.
² Department of Clinical and Biological Sciences, University of Turin, 10125 Turin, Italy.

Abstract

Chronic liver disease (CLD) is a major global health threat and has emerged as a leading cause of human death [...].

The authors declare no conflict of interest.

1. Cheemerla S., Balakrishnan M. Global Epidemiology of Chronic Liver Disease. Clin. Liver Dis. 2021;17:365–370. doi: 10.1002/cld.1061. - DOI - PMC - PubMed
1. Yin X., Guo X., Liu Z., Wang J. Advances in the Diagnosis and Treatment of Non-Alcoholic Fatty Liver Disease. Int. J. Mol. Sci. 2023;24:2844. doi: 10.3390/ijms24032844. - DOI - PMC - PubMed
1. Cannito S., Dianzani U., Parola M., Albano E., Sutti S. Inflammatoryprocessesinvolved in NASH-relatedhepatocellular carcinoma. Biosci. Rep. 2023;43:BSR20221271. doi: 10.1042/BSR20221271. - DOI - PMC - PubMed
1. Winarto J., Song D.G., Pan C.H. The Role of Fucoxanthin in Non-Alcoholic Fatty Liver Disease. Int. J. Mol. Sci. 2023;24:8203. doi: 10.3390/ijms24098203. - DOI - PMC - PubMed
1. Qiao A., Ma W., Jiang Y., Han C., Yan B., Zhou J., Qin G. Hepatic Sam68 Regulates Systemic Glucose Homeostasis and Insulin Sensitivity. Int. J. Mol. Sci. 2022;23:11469. doi: 10.3390/ijms231911469. - DOI - PMC - PubMed